IFNA1 and COVID-19: Although both IFN-λ and IFN-α/β could reduce the viral load in COVID-19 patients and decreased the incidence of hospitalization (9, –, 11), it remains unclear whether and how both types of IFN might regulate the antiviral response in upper airway epithelial cells, which results in protection against virus infection and olfactory dysfunction.